The results of the RIO Europe 2 years (Rimonabant In Obesity), COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) and CLARITY (CLopidogrel as Adjunctive ReperfusIon TherapY - Thrombolysis In Myocardial Infarction Study 28), were presented on March 9, 2005 in Orlando, Florida, at the meeting of the American College of Cardiology. Audio webcast of the conference call with financial analysts, investors and journalists given by Marc Cluzel (Senior Vice President International Development, Science and Medical Affairs).